Drugs / Zofenopril
Zofenopril
also known as
SO 26991 · SQ 26991 · Zofenil · ZOFENOPRIL CALCIUM · Zofenopril calcium salt · Zoprace
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02817360 | Feb 2016 → Dec 2025 overdue | heart disorder, type 2 diabetes mellitus | Martin Huelsmann | Recruiting | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 4 | NCT05279807 Comparator | Oct 2021 → Apr 2022 | hypertensive disorder | Menarini International Operations Luxembourg SA | Completed | No outcome recorded |
| Phase 4 | NCT05257148 Comparator | May → Dec 2021 | hypertensive disorder | Menarini International Operations Luxembourg SA | Completed | No outcome recorded |
| Phase 4 | NCT04254042 Comparator | Oct 2018 → May 2019 | hypertensive disorder | Yaounde Central Hospital | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zofenopril | “Zofenopril 60mg/d” NCT02817360 ↗ |
| Known as | SO 26991 | ChEMBL registry synonym — accepted as the source's own label CHEMBL331378 ↗ |
| Known as | SQ 26991 | ChEMBL registry synonym — accepted as the source's own label CHEMBL331378 ↗ |
| Known as | Zofenil | ChEMBL registry synonym — accepted as the source's own label CHEMBL331378 ↗ |
| Known as | ZOFENOPRIL CALCIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL331378 ↗ |
| Known as | Zofenopril calcium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL331378 ↗ |
| Known as | Zoprace | ChEMBL registry synonym — accepted as the source's own label CHEMBL331378 ↗ |
| Modality | Small molecule | — CHEMBL331378 ↗ |
| Route | Oral | “Film-Coated tablets administered as one single dose to be taken in the morning (from 6 am to 10 am) with no restriction on food intake” NCT05257148 ↗ |